Technical Analysis for CLSD - Clearside Biomedical, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
20 DMA Resistance | Bearish | -0.78% | |
Shooting Star Candlestick | Bearish | -0.78% | |
Bollinger Band Squeeze | Range Contraction | -0.78% | |
Doji - Bearish? | Reversal | -0.78% | |
Doji - Bullish? | Reversal | -0.78% | |
Outside Day | Range Expansion | -0.78% | |
Fell Below 20 DMA | Bearish | -0.78% | |
Bollinger Band Squeeze | Range Contraction | -0.78% |
Alert | Time |
---|---|
10 DMA Resistance | about 13 hours ago |
20 DMA Resistance | about 13 hours ago |
Up 3% | about 13 hours ago |
Down 2 % | about 13 hours ago |
Down 1% | about 13 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Clearside BioMedical, Inc., a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Eye Ophthalmology Macular Degeneration Macular Edema Retina Veins Wet Age Related Macular Degeneration Drug Therapies Uveitis Adverum Biotechnologies Non Infectious Uveitis Retinal Vein Occlusion
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Eye Ophthalmology Macular Degeneration Macular Edema Retina Veins Wet Age Related Macular Degeneration Drug Therapies Uveitis Adverum Biotechnologies Non Infectious Uveitis Retinal Vein Occlusion
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.12 |
52 Week Low | 0.6501 |
Average Volume | 430,202 |
200-Day Moving Average | 1.15 |
50-Day Moving Average | 1.45 |
20-Day Moving Average | 1.29 |
10-Day Moving Average | 1.29 |
Average True Range | 0.12 |
RSI (14) | 44.75 |
ADX | 18.73 |
+DI | 12.52 |
-DI | 13.30 |
Chandelier Exit (Long, 3 ATRs) | 1.12 |
Chandelier Exit (Short, 3 ATRs) | 1.46 |
Upper Bollinger Bands | 1.40 |
Lower Bollinger Band | 1.19 |
Percent B (%b) | 0.38 |
BandWidth | 15.92 |
MACD Line | -0.04 |
MACD Signal Line | -0.04 |
MACD Histogram | 0.0052 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.40 | ||||
Resistance 3 (R3) | 1.41 | 1.37 | 1.38 | ||
Resistance 2 (R2) | 1.37 | 1.34 | 1.37 | 1.37 | |
Resistance 1 (R1) | 1.32 | 1.32 | 1.30 | 1.31 | 1.36 |
Pivot Point | 1.29 | 1.29 | 1.28 | 1.28 | 1.29 |
Support 1 (S1) | 1.23 | 1.25 | 1.22 | 1.23 | 1.18 |
Support 2 (S2) | 1.20 | 1.23 | 1.20 | 1.17 | |
Support 3 (S3) | 1.15 | 1.20 | 1.16 | ||
Support 4 (S4) | 1.14 |